It’s official: several pharmaceutical companies have announced successful Phase III trials for a COVID-19 vaccine. Both Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) have reported an efficacy rate of close to 95% for their respective vaccines. This jubilant news has lifted stock markets around the world as countries breathe a collective sigh of relief. After enduring nearly a year of harsh measures such as lockdowns, border closures and movement restrictions, an end to these draconian measures seems on the cards. Businesses that were ravaged by the coronavirus at the beginning of the year may enjoy some respite soon. However, there are still logistics and storage challenges to be worked out for the vaccines to be effectively disseminated to the general populace. Still, the world is now awash with optimism that has lifted stock prices and valuations across the board. We took a look at various industries this week to see how they have been coping with the pandemic....